WQW-16119-77690
4 vaccinations
2 coded responses
22 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 816 / CO
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 2 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-20
-
2021-03-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-23
- 2021-03-24
- 2021-03-27
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-06-17
-
2021-11-30
Dose 3 — Moderna
- 2022-03-18
-
2022-05-31
Survey response — 6 months, dose 3MedDRA: Morning sickness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Morning sicknessMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Dose 4 — Pfizer-BioNTech
- 2022-09-25
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
-
2022-12-16
Survey response — 3 months, dose 4MedDRA: COVID-19, Cough, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Unevaluable event, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: COVID - fever, sore throat, cough, wheezing, congestion, mild contractionsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-16
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-11-30 | Moderna | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-16 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Morning sickness
Release 12 — 3 months, dose 4
Symptoms: COVID - fever, sore throat, cough, wheezing, congestion, mild contractions
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Morning sickness | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release